Is Pharmaust Ltd halal to invest in?

As of July 2026, Pharmaust Ltd PAA.AX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Pharmaust Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pharmaust Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Pharmaust Ltd?

Muslim investors may consider investing in Pharmaust Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Pharmaust Ltd classified as HALAL?

Musaffa determines the Shariah status of Pharmaust Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Pharmaust Ltd updated?

The Shariah compliance status of Pharmaust Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Pharmaust Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Pharmaust Ltd?

You can check the latest Shariah compliance status of Pharmaust Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Pharmaust Ltd PAA.AX

Last Updated: Nov 22, 12:00 AM·XSTU

PAA.AX Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Pharmaust Ltd is classified as halal.

HALAL

Report Source: 2023 Annual Report

Pharmaust Ltd. Stock Analysis PAA.AX

Germany Health Care Micro Cap Report: 2023 Annual

PharmAust Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-10-05. The Company’s segments include Corporate and Research. The firm is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The firm's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The firm is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. The company is focused on starting Phase II/III clinical study of MPL. The company has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. The company is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.

Key Statistics of Pharmaust Ltd (PAA.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.20AUD0.21

Today's Open

AUD0.20

Volume

292.07K

P/E Ratio (TTM)

52 Week Range

AUD0.06AUD0.12

Market Cap

105.39M

Avg. Volume

164.48K

Dividend Yield

Financial Metrics & Statements of Pharmaust Ltd (PAA.AX)

Super Investors Invested in Pharmaust Ltd (PAA.AX)

FAQ's for Pharmaust Ltd (PAA.AX)

As of July 2026, Pharmaust Ltd PAA.AX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pharmaust Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Pharmaust Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Pharmaust Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Pharmaust Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Pharmaust Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.